Arm/site/triplet | Baseline HIV prevalence | HIV incidence* | Stability/instability | Responsiveness/resistance | |
---|---|---|---|---|---|
ARM A | |||||
Z2 | Triplet 1 | 16.30% (14.2, 18.7) | 1.64 (1.09, 2.38) | Mixed | Resistant |
Z5 | Triplet 2 | 17.40% (15.8, 19.2) | 1.57 (1.08, 2.2) | Unstable | Mixed |
Z8 | Triplet 3 | 18.30% (16.5, 20.3) | 1.36 (0.86, 2.04) | Stable | Resistant |
Z10 | Triplet 4 | 25.90% (23.9, 28) | 1.93 (1.39, 2.62) | Unstable | Resistant |
S14 | Triplet 5 | 29.90% (28, 31.9) | 2.36 (1.65, 3.27) | Mixed | Resistant |
S16 | Triplet 6 | 24.90% (23.1, 26.9) | 1.43 (0.93, 2.1) | Unstable | Resistant |
S19 | Triplet 7 | 10.8% | 0.5% | Unstable | Resistant |
ARM B | |||||
Z1 | Triplet 1 | 17.0% (14.7, 19.4) | 0.94 (0.57, 1.48) | Stable | Responsive |
Z6 | Triplet 2 | 23.4% (21.7, 25.1) | 1.2 (0.8, 1.72) | Stable | Mixed |
Z9 | Triplet 3 | 21.5% (19.4, 23.7) | 1.3 (0.81, 1.97) | Mixed | Mixed |
Z11 | Triplet 4 | 24.2% (22.1, 26.4) | 1.13 (0.68, 1.76) | Mixed | Mixed |
SA13 | Triplet 5 | 29.2% (27.4, 31.1) | 1.8 (1.24, 2.53) | Mixed | Resistant |
SA18 | Triplet 6 | 19.9% (18.3, 21.5) | 1.24 (0.81, 1.82) | Mixed | Responsive |
SA20 | Triplet 7 | 9.9% (8.7, 11.3) | 0.4 (0.19, 0.74) | Stable | Responsive |
ARM C | |||||
Z3 | Triplet 1 | 21.9% (20, 23.9) | 1.17 (0.75, 1.74) | Stable | Mixed |
Z4 | Triplet 2 | 18.1% (16.4, 20) | 1.48 (1.02, 2.07) | Stable | Responsive |
Z7 | Triplet 3 | 19.6% (18, 21.4) | 1.63 (1.1, 2.33) | Mixed | Resistant |
Z12 | Triplet 4 | 28.1% (25.5, 30.9) | 2.39 (1.69, 3.29) | Unstable | Mixed |
SA15 | Triplet 5 | 28.0% (26, 30.1) | 2.15 (1.43, 3.1) | Mixed | Resistant |
SA17 | Triplet 6 | 35.7% (33.6, 37.8) | 2.31 (1.58, 3.27) | Unstable | Resistant |
SA21 | Triplet 7 | 3.0% (2.2, 4) | 0.65 (0.36, 1.09) | Stable | Resistant |